2-phenyl-pyrrole-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester | 870721-47-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 2-phenyl-pyrrole-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester
• 英文别名: 1-O-tert-butyl 3-O-ethyl 2-phenylpyrrole-1,3-dicarboxylate
• CAS: 870721-47-4
• 化学式: C₁₈H₂₁NO₄
• 分子量: 315.369
• InChiKey: GDWCQICDWDPFFB-UHFFFAOYSA-N

物化性质

• 沸点：
  447.7±47.0 °C(Predicted)
• 密度：
  1.10±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  57.5
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-phenyl-pyrrole-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 在 盐酸 、 platinum(IV) oxide 、 叠氮磷酸二苯酯 、 氢气 、 碳酸氢钠 、 三乙胺 作用下， 以 1,4-二氧六环 、 乙醇 、 水 、 甲苯 为溶剂， 20.0~80.0 ℃ 、310.27 kPa 条件下， 生成
  参考文献：
  名称：

  Discovery of Novel, Potent, and Selective Inhibitors of 3-Phosphoinositide-Dependent Kinase (PDK1)

  摘要：

  Analogues substituted with various amines at the 6-position of the pyrazine ring on (4-amino-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)pyrazin-2-ylmethanone were discovered as potent and selective inhibitors of PDK1 with potential as anticancer agents. An early lead with 2-pyridine-3-ylethylamine as the pyrazine substituent showed moderate potency and selectivity. Structure-based drug design led to improved potency and selectivity against PI3K alpha through a combination of cyclizing the ethylene spacer into a saturated, five-membered ring and substituting on the 4-position of the aryl ring with a fluorine. ADME properties were improved by lowering the lipophilicity with heteroatom replacements in the saturated, five-membered ring. The optimized analogues have a PDK1 K-i of 1 nM and >100-fold selectivity against PI3K/AKT-pathway kinases. The cellular potency of these analogues was assessed by the inhibition of AKT phosphorylation (T308) and by their antiproliferation activity against a number of tumor cell lines.

  DOI：

  10.1021/jm201019k
• 作为产物：
  描述：

  苯甲醛 在 三氟化硼乙醚 、 potassium tert-butylate 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 生成 2-phenyl-pyrrole-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester
  参考文献：
  名称：

  Discovery of Novel, Potent, and Selective Inhibitors of 3-Phosphoinositide-Dependent Kinase (PDK1)

  摘要：

  Analogues substituted with various amines at the 6-position of the pyrazine ring on (4-amino-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)pyrazin-2-ylmethanone were discovered as potent and selective inhibitors of PDK1 with potential as anticancer agents. An early lead with 2-pyridine-3-ylethylamine as the pyrazine substituent showed moderate potency and selectivity. Structure-based drug design led to improved potency and selectivity against PI3K alpha through a combination of cyclizing the ethylene spacer into a saturated, five-membered ring and substituting on the 4-position of the aryl ring with a fluorine. ADME properties were improved by lowering the lipophilicity with heteroatom replacements in the saturated, five-membered ring. The optimized analogues have a PDK1 K-i of 1 nM and >100-fold selectivity against PI3K/AKT-pathway kinases. The cellular potency of these analogues was assessed by the inhibition of AKT phosphorylation (T308) and by their antiproliferation activity against a number of tumor cell lines.

  DOI：

  10.1021/jm201019k

文献信息

• [EN] 3-AMINO-2-PHENYLPYRROLIDINE DERIVATIVES<br/>[FR] DERIVES DE 3-AMINO-2-PHENYLPYRROLIDINE
  申请人：PFIZER PROD INC

  公开号：WO2005115976A1

  公开（公告）日：2005-12-08

  3-amino-2-phenylpyrrolidine compounds useful as NK-1 antagonists, with pharmaceutical compositions and methods of treatment comprising same, are disclosed.

  抗NK-1的3-氨基-2-苯基吡咯烷化合物，以及包含这些化合物的药物组合物和治疗方法被披露。
• 3-amino-2-phenylpyrrolidine derivatives
  申请人：Humphrey Michael John

  公开号：US20050288358A1

  公开（公告）日：2005-12-29

  3-amino-2-phenylpyrrolidine compounds useful as NK-1 antagonists, with pharmaceutical compositions and methods of treatment comprising same, are disclosed.

  本文披露了作为NK-1拮抗剂有用的3-氨基-2-苯基吡咯烷化合物，以及包含它们的制药组合物和治疗方法。
• 3-AMINO-2-PHENYLPYRROLIDINE DERIVATIVES
  申请人：Humphrey John Michael

  公开号：US20080221151A1

  公开（公告）日：2008-09-11

  3-amino-2-phenylpyrrolidine compounds useful as NK-1 antagonists, with pharmaceutical compositions and methods of treatment comprising same, are disclosed.

  本发明公开了作为NK-1拮抗剂有用的3-氨基-2-苯基吡咯烷化合物，以及包含其的制药组合物和治疗方法。
• US7381741B2
  申请人：——

  公开号：US7381741B2

  公开（公告）日：2008-06-03
• [EN] 6-OXODECAHYDROPYRROLO[1,2-A][1,5]DIAZOCINE AND 6-OXODECAHYDRO-4H-PYRROLO[2,1-D][1,5]THIAZOCINE DERIVATIVES AS STAT3 AND STAT6 MODULATORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS<br/>[FR] DÉRIVÉS DE 6-OXODÉCAHYDROPYRROLO [1,2-A] [1,5] DIAZOCINE ET DE 6-OXODÉCAHYDRO-4 H-PYRROLO [2,1-D] [1,5] THIAZOCINE EN TANT QUE MODULATEURS STAT3 ET STAT6 POUR LE TRAITEMENT DU CANCER ET D'ÉTATS INFLAMMATOIRES
  申请人：[en]RECLUDIX PHARMA, INC.

  公开号：WO2023164680A1

  公开（公告）日：2023-08-31

  Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with STAT3 and/or STAT6, such as e.g. cancer and inflammatory conditions. Preferred compounds are 6-oxodecahydropyrrolo[1,2-a][1,5]diazocine and 6-oxodecahydro-4H-pyrrolo[2,1-d][1,5]thiazocine derivatives.